A Case of Recurrent Fixed Drug Eruption Secondary to Desloratadine.

Author: AlmukhadebEman

Paper Details 
Original Abstract of the Article :
Desloratadine is a second-generation H1-type antihistamine that is widely prescribed for multiple indications including allergic rhinitis and urticaria. It is well-tolerated and is not known to cause cutaneous side effects including fixed drug eruption (FDE). In this report, a case of recurrent fixe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403490/

データ提供:米国国立医学図書館(NLM)

A Case of Recurrent Fixed Drug Eruption Secondary to Desloratadine

Navigating the world of drug reactions, like traversing a desert with hidden dangers, requires a keen understanding of potential side effects. This case report sheds light on a rare but potentially severe adverse drug reaction, fixed drug eruption (FDE), triggered by the commonly prescribed antihistamine desloratadine.

The report describes a patient who experienced recurrent FDE after taking desloratadine, a medication often used to alleviate allergies. This discovery, like encountering a venomous snake in the desert, underscores the importance of vigilance and prompt diagnosis when patients experience unexpected skin reactions.

Desloratadine and FDE: A Cautionary Tale

This case report, like a warning sign in the desert, serves as a reminder of the potential for unexpected drug reactions. It highlights the importance of carefully monitoring patients for any adverse effects, even from medications commonly considered safe.

Dr. Camel's Conclusion

This case report, like a flickering torch illuminating a hidden path, offers a cautionary tale about the potential for unexpected drug reactions, even from seemingly safe medications. It emphasizes the need for careful monitoring and prompt diagnosis to ensure patient safety. As we navigate the complex world of pharmaceuticals, we must remain vigilant, just as a seasoned traveler carefully observes the landscape of the desert for potential hazards.

Date :
  1. Date Completed n.d.
  2. Date Revised 2021-09-04
Further Info :

Pubmed ID

34476136

DOI: Digital Object Identifier

PMC8403490

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.